Financial statements F1 Pharma
Cash flow statement of F1 Pharma
Company age:
Age:
6 y. 4 m. 1 d.
Share capital:
Share capital:
1 669 800 PLN
Cash inflows of F1 PHARMA
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Net cash from operating expenses | -211 159,17 | 73 656,77 | 33 614,54 | -430 717,38 | -13 309,32 |
| Net cash flow from investing activities | -73 153,66 | -20 515,20 | -15 328,60 | -3 291,06 | 0,00 |
| Net cash flow from financial activities | -760,71 | 293 261,32 | -32 949,06 | -55 749,56 | -26 280,21 |
| Total net cash flow | -285 073,54 | 346 402,89 | -14 663,12 | -489 758,00 | -39 589,53 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.